Corrigendum: Interference With Coagulation Cascade as a Novel Approach to Counteract Cisplatin-Induced Acute Tubular Necrosis; an Experimental Study in Rats

Front Pharmacol. 2019 Oct 24:10:1259. doi: 10.3389/fphar.2019.01259. eCollection 2019.

Mohamed G Ewees¹, Basim A S Messiha², Ali A Abo-Saif^{1

3}, Asmaa M A Bayoumi⁴, Mohamed S Abdel-Bakky^{1

5}

¹ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt.
² Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
³ Department of Pharmacology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
⁴ Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt.
⁵ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.

Abstract

[This corrects the article DOI: 10.3389/fphar.2018.01155.].

Keywords: cisplatin; coagulation cascade; fibrin; nephrotoxicity; rivaroxaban; tissue factor.